Fig. 1From: Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials GroupImpact of the correlation coefficient on the confidence intervals of the incremental net benefit across willingness-to-pay valuesBack to article page